Advertisement

Endocrine Pathology

, Volume 16, Issue 3, pp 229–238 | Cite as

Expression of heterogeneous nuclear ribonucleoproteins A2 and B1 in the thyroid follicular cells

  • Yukiko Yano
  • WenWen Wu
  • Hiroshi Kamma
  • Masachika Fujiwara
  • Hisato Hara
  • Tohru Yashiro
  • Ei Ueno
  • Masanao Miwa
  • Yuji Aiyoshi
Clinical Research

Abstract

Several proteins implicated in hormonogenesis of the thyroid have alternatively spliced isoforms. Alternative splicing of pre-mRNA is considered to be important to regulate the hormonal activity. Heterogeneous nuclear ribonucleoproteins (hnRNP) A2 and B1 are two of the abundant nuclear RNA-binding proteins involved in alternative splicing. We examined the expression of hnRNP A2 and B1 in the thyroid, paying particular attention to the relationship between their function and the cellular morphology. B1 was expressed more frequently in cuboidal follicular cells that are hormonally active than in flat follicular cells in normal thyroid, although A2 expression showed no significant difference in two cell types. In Graves’ disease, the patients who had high serum levels of triiodothyronine and thyroxine showed significantly increased expression of B1. B1 expression did not differ significantly between normal thyroids and thyroid neoplasms, except undifferentiated (anaplastic) carcinoma. Conclusively, B1 expression varied in relation to hormonal activity in thyroid follicular cells. B1 protein is a good immunohistological marker to detect hormonal activity of follicular cells, and may provide a key to elucidate the splicing mechanisms involved in thyroid hormonogenesis.

Key Words

Graves’ disease hnRNP A2/B1 hormonal activity thyroid cancer thyroid function 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kawaoi A, Okano T, Nemoto N, et al. Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and Triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method. Am J Pathol 108:39–49, 1982.PubMedGoogle Scholar
  2. 2.
    Lalli E, Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem 269:17359–17362, 1994.PubMedGoogle Scholar
  3. 3.
    Walker WH, Girardet C, Habener JF. Alternative exon splicing controls a translational switch from activator to repressor isoforms of transcription factor CREB during spermatogenesis. J Biol Chem 271:20145–21050, 1996.PubMedCrossRefGoogle Scholar
  4. 4.
    Yin JC, Wallach JS, Wilder EL, et al. A Drosophila CREB/CREM homolog encodes multiple isoforms, including a cyclic AMP-dependent protein kinase-responsive transcriptional activator and antagonist. Mol Cell Biol 15:5123–5130, 1995.PubMedGoogle Scholar
  5. 5.
    Yang K, Yu M, Han VK. Identification and tissue distribution of a novel variant of beta-hydroxysteroid dehydrogenase 1 transcript. J Steroid Biochem Mol Biol 55:247–253, 1995.PubMedCrossRefGoogle Scholar
  6. 6.
    Martin MM, Willardson BM, Burton GF, et al. Human angiotensin II type I receptor isoforms encoded by messenger RNA splice variants are functionally distinct. Mol Endocrinol 15:281–293, 2001.PubMedCrossRefGoogle Scholar
  7. 7.
    Rotzer D, Roth M, Lutz M, Lindemann D, Sebald W, Knaus P. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. Embo J 20:480–490, 2001.PubMedCrossRefGoogle Scholar
  8. 8.
    Pinol-Roma S, Choi YD, Matunis MJ, Dreyfuss G. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev 2:215–227, 1988.PubMedGoogle Scholar
  9. 9.
    Krecic AM, Swanson MS. hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11:363–371, 1999.PubMedCrossRefGoogle Scholar
  10. 10.
    Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289–321, 1993.PubMedCrossRefGoogle Scholar
  11. 11.
    Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. Embo J 13:5483–5495, 1994.PubMedGoogle Scholar
  12. 12.
    Kamma H, Satoh H, Matusi M, Wu WW, Fujiwara M, Horiguchi H. Characterization of hnRNP A2 and B1 using monoclonal antibodies: intracellular distribution and metabolism through cell cycle. Immunol Lett 76:49–54, 2001.PubMedCrossRefGoogle Scholar
  13. 13.
    Wu W, Kamma H, Fujiwara M, et al. Altered expression patterns of heterogeneous nuclear ribonucleoprotein A2 and B1 in adrenal cortex. J Histochem Cytochem 53:487–495, 2005.PubMedCrossRefGoogle Scholar
  14. 14.
    Snead DR, Perunovic B, Cullen N, et al. hnRNP B1 expression in benign and malignant lung disease. J Pathol 200:88–94, 2003.PubMedCrossRefGoogle Scholar
  15. 15.
    Satoh H, Kamma H, Ishikawa H, et al. Expression of hnRNP A2/B1 proteins in human cancer cell lines. Int J Oncol 16:763–767, 2000.PubMedGoogle Scholar
  16. 16.
    Matsuyama S, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn J Cancer Res 91:658–663, 2000.PubMedGoogle Scholar
  17. 17.
    Bidot P, Morgan M, Zhukov T, Tannenbaum M, Tockman MS. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. Endocr Pract 7:157–161, 2001.PubMedGoogle Scholar
  18. 18.
    Wu W, Kamma H, Ueno E, et al. The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy. Oncol Rep 9:1027–1031, 2002.PubMedGoogle Scholar
  19. 19.
    Ericson LE. Exocytosis and endocytosis in the thyroid follicle cell. Mol Cell Endocrinol 22:1–24, 1981.PubMedCrossRefGoogle Scholar
  20. 20.
    Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667–697, 1992.PubMedGoogle Scholar
  21. 21.
    Harcourt-Webster JN, Stott NC. Histochemical study of oxidative and hydrolytic enzymes in the human thyroid. J Pathol Bacteriol 92:291–302, 1966.PubMedCrossRefGoogle Scholar
  22. 22.
    Fragu P, Nataf BM. Human thyroid peroxidase activity in benign and malign thyroid disorders. J Clin Endocrinol Metab 45:1089–1096, 1977.PubMedCrossRefGoogle Scholar
  23. 23.
    Tanaka T, Umeki K, Yamamoto I, Sugiyama S, Noguchi S, Ohtaki S. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression. J Pathology 179:89–94, 1996.CrossRefGoogle Scholar
  24. 24.
    Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 59:1404–1407, 1999.PubMedGoogle Scholar
  25. 25.
    Hamasaki M, Kamma H, Wu W, et al. Expression of hnRNP B1 in four major histological types of lung cancers. Anticancer Res 21:979–984, 2001.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2005

Authors and Affiliations

  • Yukiko Yano
    • 1
  • WenWen Wu
    • 2
  • Hiroshi Kamma
    • 4
  • Masachika Fujiwara
    • 4
  • Hisato Hara
    • 1
  • Tohru Yashiro
    • 1
  • Ei Ueno
    • 1
  • Masanao Miwa
    • 3
  • Yuji Aiyoshi
    • 1
  1. 1.Institute of Clinical MedicineUniversity of TsukubaIbarakiJapan
  2. 2.School of MedicineSt. Marianna UniversityKanagawaJapan
  3. 3.Institute of Basic Medical SciencesUniversity of TsukubaIbarakiJapan
  4. 4.Department of PathologyKyorin University, School of MedicineTokyoJapan

Personalised recommendations